Oncocyte Corporation (OCX) Fundamentals

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests.
SHARE INFORMATION
Market CapUS$ 50 423 624
Shares Outstanding118 643 821
Float78 695 360
Percent Float66,33%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 7 727 000
Latest Fiscal EPSUS$ -0,72
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions197
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months174 083
Institutional Holdings Percent67,1%
Institutional Sold Previous 3 Months7 295 205
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months563 797
Insider Holdings Percent5,4
Insider Sold Previous 3 Months1 118 960
Insider Shares Owned6 441 528
TRADING INFO
52 Week HighUS$ 1,82
52 Week LowUS$ 0,24
52 Week High ChangeUS$ -72,04
21 Day Moving AverageUS$ 0,4107
21 Day Extended Moving AverageUS$ 0,426209
50 Day Moving AverageUS$ 0,4111
50 Day Extended Moving AverageUS$ 0,455561
200 Day Moving AverageUS$ 0,792238
200 Day Extended Moving AverageUS$ 0,90924
10 Day Average Volume170 157
20 Day Average Volume256 966
30 Day Average Volume404 266
50 Day Average Volume379 082
Alpha-0.010607
Beta1.6393
Standard Deviation0.397515
R20.049451
7 Day Price ChangeUS$ -0,0255
7 Day Percent Change-5,66%
21 Day Price ChangeUS$ 0,0369
21 Day Percent Change9,51%
30 Day Price ChangeUS$ 0,104
30 Day Percent Change32,4%
Month to Date Price ChangeUS$ 0,1041
Month to Date Percent Change32,44%
Quarter to Date Price ChangeUS$ 0,1041
Quarter to Date Percent Change32,44%
180 Day Price ChangeUS$ -0,4143
180 Day Percent Change-49,36%
200 Day Price ChangeUS$ -0,4496
200 Day Percent Change-51,41%
Year to Date Price ChangeUS$ 0,1041
Year to Date Percent Change32,44%

Oncocyte Corporation (OCX) Key Ratios

PROFITABILITY
EBIT Margin-785,5%
EBITDA Margin-721,4%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin-8,1%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 4 508 000
Revenue Per ShareUS$ 0,038
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-1,70
Total Debt To Equity0,10
Int Coverage-594,40
Current Ratio2,80
Leverage Ratio2,20
Quick Ratio2,70
Long Term Debt To Capital0,04
VALUATION MEASURES
PE Ratio-0,60
Enterprise ValueUS$ 21 713 623
Price to Sales11,1854
Price to Free Cash-1,30
PE High Last 5 Years-7,60
Price To Book0,70
Price To Cash Flow0,00
PE Low Last 5 Years-8,40
Price to Tangible Book-1,70
MANAGEMENT EFFECTIVENESS
Receivables Turnover2,70
Invoice Turnover66,80
Assets Turnover0,00
Return Assets-42,74
Return on Equity-79,62
Return on Capital-68,79

Oncocyte Corporation (OCX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWithumSmith+Brown, PC
CEOJoshua Riggs
Emplyoees115
Last AuditUQ
CIK0001642380
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address15 Cushing
Irvine, CA 92618
Websitehttps://www.oncocyte.com
Facsimile-
Telephone+1 949 409-7600
EmailAPrior@evcgroup.com
Dernières Valeurs Consultées
AMEX
OCX
OncoCyte
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20230208 17:32:38